eXoZymes, Inc. (EXOZ)
eXoZymes, Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in Monrovia, CA, US. The stock last traded at $5.88, up 2.00% on the session, giving a market capitalisation of $54.5M. On trailing twelve-month figures it carries a trailing P/E of -5.11, a net margin of 0.0%. Its beta of 2.93 implies it has historically moved more than the broad market.
eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.
eXoZymes, Inc. is most often compared with the following Healthcare names: